2,7-Dimethyl-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one

Catalog No.: 
ACMAPD825
CAS No.: 
41914-67-4
Molecular Formula: 
C7H7N3OS
Molecular Weight: 
181.22
2,7-Dimethyl-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%
1g97%
5g97%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,7-Dimethyl-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one
IUPAC Name2,7-dimethyl-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one
Molecular FormulaC7H7N3OS
Molecular Weight181.22
SMILESO=C1C=C(C)N=C2N1N=C(C)S2
InChI KeyCCPIYFUPVOFKMV-UHFFFAOYSA-N
Synonym2,7-Dimethyl-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one;5H-1,3,4-Thiadiazolo[3,2-a]pyrimidin-5-one, 2,7-dimethyl-
CAS No.41914-67-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACMAPD825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBFZJ823 route compound structure diagram
    ACBFZJ82314284-93-6In Stock
  2. Plus
  3. ACYVPK267 route compound structure diagram
    ACYVPK2671603-91-4In Stock
  4. Then
  5. ACMAPD825 route product structure diagram
    ACMAPD82541914-67-4
Inquiry

2. ACMAPD825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMAPD825 route product structure diagram
    ACMAPD82541914-67-4
Inquiry

3. ACMAPD825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMAPD825 route product structure diagram
    ACMAPD82541914-67-4
Inquiry

Comments (0)